Europe – 38ème organisme notifié au titre du Règlement 2017/745 

38ème organisme notifié au titre du Règlement 2017/745 

Europe – IA: la Commission européenne renforce l’exigence de garantie humaine

PARIS (TICpharma) - Le futur règlement européen sur l'intelligence artificielle (IA) devrait être finalisé "début 2023", signant le "top chrono" pour la mise en...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Notified bodies concerned with lack of MDR/IVDR applications as deadlines approach

Notified body (NB) capacity has risen significantly in recent years as the number of designations has increased; however, some manufacturers have yet to transition...
Vers une plus grande coopération des pharmacopées mondiales

Europe – Team-NB asks for regulatory clarity and for manufacturers to not delay MDR...

Notified bodies (NB) say that while extending the deadline to transition to EU Medical Device Regulation (MDR) has been a positive move, there is...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Squamous cell carcinoma (SCC) and different types of lymphomas occurring in the...

MHRA is aware of a very small number of cases of squamous cell carcinoma (SCC) and different types of lymphoma, found within the fibrous capsule...
Advice for Management of Clinical trials in relation to Coronavirus

UK – Borderline products: how to tell if your product is a medical device...

Some products are hard to distinguish from a medical device, for example products that might be medicines, cosmetics, food supplements, biocidal products or personal...

Europe – Factsheet for authorities in non-EU/EEA states on medical devices and in vitro...

In April 2017, the European Parliament and the Council adopted the Medical Devices Regulation (EU) 2017/745 (MDR) and the In Vitro Diagnostic Medical Devices...

Europe – Nouveau Organisme notifié au titre du Règlement (UE) 2017/745

Nouveau Organisme notifié au titre du Règlement (UE) 2017/745
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2023-7 Guidance on exemptions from the requirement to perform clinical investigations...

In the case of implantable devices and class III devices, clinical investigations shall be performed, except if: — the device has been designed by modifications of...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical devices: UK approved bodies

UK approved bodies listed under Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002)...

NOS PROCHAINES FORMATIONS